From The Editor
This article was originally published in SRA
Executive Summary
You've counted on Scrip Regulatory Affairs and its predecessors for many years for unrivalled coverage of global pharmaceutical and medtech regulatory affairs. Now we're making some exciting changes that will significantly enhance and expand the breadth and global reach of the content you receive.